Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • My Role
  • Membership
  • Learning
  • Get Involved
  • Careers
  • About ASCP
  • Board of Certification
  • News
  • News
  • News Archive
  • Groups
  • Jobs
  • ASCP
  • News Archive
  • News Detail

ACLA Scores Major Legal Win in PAMA Lawsuit

Publication Date: Aug 2, 2019

On July 30, the U.S. Court of Appeals ruled in favor of the American Clinical Laboratory Association (ACLA) in the case of ACLA v. Azar. The lawsuit challenges the flawed data collection process established by U.S. Department of Health and Human Services (HHS) to develop a new Clinical Laboratory Fee Schedule (CLFS).

When Congress enacted the Protecting Access to Medicare Act (PAMA), it required HHS to develop a new “market rate” CLFS based on private payer data collected from applicable clinical laboratories. However, in constructing a new fee schedule, the Agency largely ignored market rate data from hospitals and other facilities that tend to receive higher wages than independent reference laboratories, thus failing to meet Congress’s requirements.

Interestingly, PAMA prohibits judicial review of the HHS’s establishment of payment rates but ACLA argued, and the court agreed, that this did not bar the courts from reviewing the final regulations establishing the data collection process. In siding with ACLA, the Court also remanded the case back to the District Court for further proceedings consistent with this opinion. ASCP strongly supported ACLA’s lawsuit against HHS and congratulates ACLA on a truly important legal victory.

Click here to access ACLA’s press release on the Court’s decision.

Other articles in the August 2019 ePolicy:

ASCP Urges Anthem to Reconsider Cuts to Pathology, Laboratory Rates
CMS (Finally) Releases 2020 CY Physician Fee Schedule
Cervical Cancer Risk Guidelines Public Comment Now Open
NASEM Committee to Identify Gaps in Clinical Practice Guidelines for Acute Pain Opioid Prescriptions

To read more articles from ePolicy News click here.

For more information regarding ASCP's advocacy initiatives and policy positions, please contact ASCP's Center for Public Policy at (202) 408-1110.

hologic-corp

 ASCP ePolicy News is supported by an unrestricted grant from Hologic.

 

 

  • My Role
    • Pathologist
    • Resident
    • Lab Professional
    • Program Directors
    • Student
  • Membership
    • Renew Membership
    • Become a Member
    • Get Involved
    • Rewards
    • Member Center
  • Learning
    • Certificate Programs
    • Attend Meetings
    • Explore Books and Journals
    • Continuous Quality Improvement & Quality Assurance
    • Access My Education
    • ACCME
    • CC Resources
    • CMP Resources
    • ASCPedia
    • Featured Education
    • Immuno-Oncology
    • ASCP Annual Meeting
    • ASCP Virtual Town Hall Series
    • Inside the Lab
  • Get Involved
    • Get Recognized
    • Receive Awards
    • Serve Your Community
    • Center for Global Health
    • Serve Your Profession
    • Partners in Cancer Diagnosis
    • Institute for Science Technology & Public Policy
    • Choosing Wisely
    • Patient Champions
    • Discover Opportunities
    • Apply to Volunteer
    • Ambassadors
    • ASCP Mentorship Program
  • Careers
    • Find a Job
    • Post a Job
    • Learn About Careers
    • Discover Fellowships
    • Work at ASCP
  • About ASCP
    • Our Mission
    • Supporting Our Members
    • Our Community Efforts
    • ASCP Foundation
    • Contact ASCP
    • Media Relations
  • Board of Certification
    • Get Credentialed
    • Stay Credentialed
    • Verify Credentials
    • Program Directors
    • About BOC
    • Apply Now/Check Status/Update Info
    • Manage Your BOC Account
    • Declaration & Complete CMP
  • News
    • ePolicy News
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021 by American Society for Clinical Pathology. All Rights Reserved.